Global Parkinson's Disease Market Research Report 2019

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Parkinson's Disease Revenue
• 1.4 Market by Type
  • 1.4.1 Global Parkinson's Disease Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Carbidopa/Levodopa
  • 1.4.3 Dopamine Receptor Agonists
  • 1.4.4 MAO-Inhibitors
• 1.5 Market by Application
  • 1.5.1 Global Parkinson's Disease Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospitals
  • 1.5.3 Clinics
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Parkinson's Disease Market Perspective (2015-2026)
• 2.2 Global Parkinson's Disease Growth Trends by Regions
  • 2.2.1 Parkinson's Disease Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Parkinson's Disease Historic Market Share by Regions (2015-2020)
  • 2.2.3 Parkinson's Disease Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Parkinson's Disease Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Parkinson's Disease Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Parkinson's Disease Players by Market Size
  • 3.1.1 Global Top Parkinson's Disease Players by Revenue (2015-2020)
  • 3.1.2 Global Parkinson's Disease Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Parkinson's Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Parkinson's Disease Market Concentration Ratio
  • 3.2.1 Global Parkinson's Disease Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Parkinson's Disease Revenue in 2019
• 3.3 Parkinson's Disease Key Players Head office and Area Served
• 3.4 Key Players Parkinson's Disease Product Solution and Service
• 3.5 Date of Enter into Parkinson's Disease Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Parkinson's Disease Historic Market Size by Type (2015-2020)
• 4.2 Global Parkinson's Disease Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Parkinson's Disease Market Size by Application (2015-2020)
• 5.2 Global Parkinson's Disease Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Parkinson's Disease Market Size (2015-2020)
• 6.2 Parkinson's Disease Key Players in North America (2019-2020)
• 6.3 North America Parkinson's Disease Market Size by Type (2015-2020)
• 6.4 North America Parkinson's Disease Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Parkinson's Disease Market Size (2015-2020)
• 7.2 Parkinson's Disease Key Players in Europe (2019-2020)
• 7.3 Europe Parkinson's Disease Market Size by Type (2015-2020)
• 7.4 Europe Parkinson's Disease Market Size by Application (2015-2020)

8 China

• 8.1 China Parkinson's Disease Market Size (2015-2020)
• 8.2 Parkinson's Disease Key Players in China (2019-2020)
• 8.3 China Parkinson's Disease Market Size by Type (2015-2020)
• 8.4 China Parkinson's Disease Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Parkinson's Disease Market Size (2015-2020)
• 9.2 Parkinson's Disease Key Players in Japan (2019-2020)
• 9.3 Japan Parkinson's Disease Market Size by Type (2015-2020)
• 9.4 Japan Parkinson's Disease Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Parkinson's Disease Market Size (2015-2020)
• 10.2 Parkinson's Disease Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Parkinson's Disease Market Size by Type (2015-2020)
• 10.4 Southeast Asia Parkinson's Disease Market Size by Application (2015-2020)

11 India

• 11.1 India Parkinson's Disease Market Size (2015-2020)
• 11.2 Parkinson's Disease Key Players in India (2019-2020)
• 11.3 India Parkinson's Disease Market Size by Type (2015-2020)
• 11.4 India Parkinson's Disease Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Parkinson's Disease Market Size (2015-2020)
• 12.2 Parkinson's Disease Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Parkinson's Disease Market Size by Type (2015-2020)
• 12.4 Central & South America Parkinson's Disease Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Teva
  • 13.1.1 Teva Company Details
  • 13.1.2 Teva Business Overview
  • 13.1.3 Teva Parkinson's Disease Introduction
  • 13.1.4 Teva Revenue in Parkinson's Disease Business (2015-2020))
  • 13.1.5 Teva Recent Development
• 13.2 Novartis
  • 13.2.1 Novartis Company Details
  • 13.2.2 Novartis Business Overview
  • 13.2.3 Novartis Parkinson's Disease Introduction
  • 13.2.4 Novartis Revenue in Parkinson's Disease Business (2015-2020)
  • 13.2.5 Novartis Recent Development
• 13.3 GSK
  • 13.3.1 GSK Company Details
  • 13.3.2 GSK Business Overview
  • 13.3.3 GSK Parkinson's Disease Introduction
  • 13.3.4 GSK Revenue in Parkinson's Disease Business (2015-2020)
  • 13.3.5 GSK Recent Development
• 13.4 AbbVie
  • 13.4.1 AbbVie Company Details
  • 13.4.2 AbbVie Business Overview
  • 13.4.3 AbbVie Parkinson's Disease Introduction
  • 13.4.4 AbbVie Revenue in Parkinson's Disease Business (2015-2020)
  • 13.4.5 AbbVie Recent Development
• 13.5 Merck
  • 13.5.1 Merck Company Details
  • 13.5.2 Merck Business Overview
  • 13.5.3 Merck Parkinson's Disease Introduction
  • 13.5.4 Merck Revenue in Parkinson's Disease Business (2015-2020)
  • 13.5.5 Merck Recent Development
• 13.6 Boehringer Ingelheim
  • 13.6.1 Boehringer Ingelheim Company Details
  • 13.6.2 Boehringer Ingelheim Business Overview
  • 13.6.3 Boehringer Ingelheim Parkinson's Disease Introduction
  • 13.6.4 Boehringer Ingelheim Revenue in Parkinson's Disease Business (2015-2020)
  • 13.6.5 Boehringer Ingelheim Recent Development
• 13.7 Amneal + Impax
  • 13.7.1 Amneal + Impax Company Details
  • 13.7.2 Amneal + Impax Business Overview
  • 13.7.3 Amneal + Impax Parkinson's Disease Introduction
  • 13.7.4 Amneal + Impax Revenue in Parkinson's Disease Business (2015-2020)
  • 13.7.5 Amneal + Impax Recent Development
• 13.8 Lundbeck
  • 13.8.1 Lundbeck Company Details
  • 13.8.2 Lundbeck Business Overview
  • 13.8.3 Lundbeck Parkinson's Disease Introduction
  • 13.8.4 Lundbeck Revenue in Parkinson's Disease Business (2015-2020)
  • 13.8.5 Lundbeck Recent Development
• 13.9 Sun Pharma
  • 13.9.1 Sun Pharma Company Details
  • 13.9.2 Sun Pharma Business Overview
  • 13.9.3 Sun Pharma Parkinson's Disease Introduction
  • 13.9.4 Sun Pharma Revenue in Parkinson's Disease Business (2015-2020)
  • 13.9.5 Sun Pharma Recent Development
• 13.10 Wockhardt
  • 13.10.1 Wockhardt Company Details
  • 13.10.2 Wockhardt Business Overview
  • 13.10.3 Wockhardt Parkinson's Disease Introduction
  • 13.10.4 Wockhardt Revenue in Parkinson's Disease Business (2015-2020)
  • 13.10.5 Wockhardt Recent Development
• 13.11 UCB
  • 10.11.1 UCB Company Details
  • 10.11.2 UCB Business Overview
  • 10.11.3 UCB Parkinson's Disease Introduction
  • 10.11.4 UCB Revenue in Parkinson's Disease Business (2015-2020)
  • 10.11.5 UCB Recent Development
• 13.12 Bausch Health
  • 10.12.1 Bausch Health Company Details
  • 10.12.2 Bausch Health Business Overview
  • 10.12.3 Bausch Health Parkinson's Disease Introduction
  • 10.12.4 Bausch Health Revenue in Parkinson's Disease Business (2015-2020)
  • 10.12.5 Bausch Health Recent Development
• 13.13 Acadia
  • 10.13.1 Acadia Company Details
  • 10.13.2 Acadia Business Overview
  • 10.13.3 Acadia Parkinson's Disease Introduction
  • 10.13.4 Acadia Revenue in Parkinson's Disease Business (2015-2020)
  • 10.13.5 Acadia Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer